Crinetics Pharmaceuticals, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Wilson Marc | CFO | Sale | 10,922 | $19.96 | $218,003 | 95,158 | Jun 20, 2023 |
| Struthers Richard Scott | President & CEO | Sale | 50,000 | $20.81 | $1,040,500 | 680,805 | Jun 16, 2023 |
| WIERENGA WENDALL | — | Award / Grant | 6,000 | — | — | 105,846 | Jun 16, 2023 |
| Vivaldi Coelho Rogerio | — | Award / Grant | 6,000 | — | — | 11,000 | Jun 16, 2023 |
| Deardorf Caren | — | Award / Grant | 6,000 | — | — | 6,000 | Jun 16, 2023 |
| Okey Stephanie | — | Award / Grant | 6,000 | — | — | 6,000 | Jun 16, 2023 |
| Nichols Weston | — | Award / Grant | 6,000 | — | — | 6,000 | Jun 16, 2023 |
| Fust Matthew K | — | Award / Grant | 6,000 | — | — | 18,536 | Jun 16, 2023 |
| Bedrosian Camille L | — | Award / Grant | 6,000 | — | — | 6,000 | Jun 16, 2023 |
| Vivaldi Coelho Rogerio | — | Purchase | 5,000 | $22.06 | $110,300 | 5,000 | Jun 8, 2023 |
| Pizzuti Dana | Chief Development Officer | Sale | 8,212 | $16.15 | $132,624 | 4,500 | Apr 3, 2023 |
| Wilson Marc | CFO | Tax Withholding | 1,666 | $17.12 | $28,522 | 106,080 | Mar 16, 2023 |
| Struthers Richard Scott | President & CEO | Tax Withholding | 4,628 | $17.12 | $79,231 | 125,522 | Mar 16, 2023 |
| Krasner Alan Seth | Chief Medical Officer | Tax Withholding | 1,687 | $17.12 | $28,881 | 42,301 | Mar 16, 2023 |
| Knight Jeff E. | Chief Operating Officer | Tax Withholding | 587 | $17.12 | $10,049 | 34,400 | Mar 16, 2023 |
| Betz Stephen F. | Chief Scientific Officer | Tax Withholding | 1,410 | $17.12 | $24,139 | 86,879 | Mar 16, 2023 |
| Hassard James | Chief Commercial Officer | Award / Grant | 14,000 | — | — | 14,000 | Mar 1, 2023 |
| Pizzuti Dana | Chief Development Officer | Award / Grant | 4,500 | — | — | 17,000 | Mar 1, 2023 |
| Krasner Alan Seth | Chief Medical Officer | Award / Grant | 19,500 | — | — | 43,988 | Mar 1, 2023 |
| Betz Stephen F. | Chief Scientific Officer | Award / Grant | 23,600 | — | — | 88,289 | Mar 1, 2023 |
| Knight Jeff E. | Chief Operating Officer | Award / Grant | 29,500 | — | — | 34,987 | Mar 1, 2023 |
| Wilson Marc | CFO | Award / Grant | 24,200 | — | — | 107,746 | Mar 1, 2023 |
| Struthers Richard Scott | President & CEO | Award / Grant | 61,650 | — | — | 130,150 | Mar 1, 2023 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 3,126 | $19.59 | $61,238 | 64,689 | Feb 1, 2023 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 8,336 | $21.07 | $175,640 | 67,815 | Jan 25, 2023 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 3,126 | $18.00 | $56,268 | 76,151 | Jan 17, 2023 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 3,126 | $18.35 | $57,362 | 79,277 | Jan 3, 2023 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 3,126 | $16.00 | $50,016 | 82,403 | Dec 15, 2022 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 3,126 | $17.84 | $55,768 | 84,968 | Dec 1, 2022 |
| Wilson Marc | CFO | Other | 1,446 | $11.02 | $15,935 | 83,064 | Nov 20, 2022 |
| Knight Jeff E. | Chief Operating Officer | Other | 537 | $15.16 | $8,141 | 5,487 | Nov 20, 2022 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 3,126 | $18.72 | $58,519 | 88,094 | Nov 15, 2022 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 3,126 | $18.52 | $57,894 | 91,220 | Nov 1, 2022 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 3,126 | $17.73 | $55,424 | 94,346 | Oct 17, 2022 |
| Struthers Richard Scott | President & CEO | Option Exercise | 11,100 | $1.91 | $21,201 | 68,500 | Oct 12, 2022 |
| Pizzuti Dana | Chief Development Officer | Award / Grant | 12,500 | — | — | 12,500 | Oct 10, 2022 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 3,126 | $19.64 | $61,395 | 97,472 | Oct 3, 2022 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 4,168 | $21.01 | $87,570 | 100,598 | Sep 15, 2022 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 1,042 | $21.00 | $21,882 | 104,766 | Sep 7, 2022 |
| Fust Matthew K | — | Sale | 5,700 | $20.96 | $119,472 | 12,536 | Jul 13, 2022 |
| Knight Jeff E. | Chief Operating Officer | Sale | 1,152 | $20.70 | $23,846 | 4,950 | May 20, 2022 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 3,126 | $18.59 | $58,112 | 105,808 | May 20, 2022 |
| Krasner Alan Seth | Chief Medical Officer | Other | 712 | $11.02 | $7,846 | 24,488 | May 20, 2022 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 3,247 | $20.10 | $65,265 | 107,598 | May 2, 2022 |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | — | Purchase | 157,515 | $22.22 | $3,499,983 | 5,321,032 | Apr 18, 2022 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 5,664 | $25.81 | $146,188 | 110,845 | Apr 18, 2022 |
| Struthers Richard Scott | President & CEO | Sale | 69,176 | $27.53 | $1,904,415 | 730,805 | Apr 13, 2022 |
| Struthers Richard Scott | President & CEO | Sale | 21,357 | $25.34 | $541,186 | 869,448 | Apr 5, 2022 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 9,000 | $23.97 | $215,730 | 116,509 | Apr 4, 2022 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 4,164 | $21.06 | $87,694 | 129,673 | Apr 1, 2022 |